(Q37770791)

22 August 2017

0 references

1 reference

title

Risk of resistance to highly active antiretroviral therapy among HIV-positive injecting drug users: a meta-analysis (English)

1 reference

22 August 2017

0 references

anti-retroviral agent

0 references

0 references

3

Julio S G Montaner

1 reference

22 August 2017

4

Evan Wood

1 reference

22 August 2017

2

Edward J Mills

1 reference

22 August 2017

Daniel Werb

1

1 reference

22 August 2017

publication date

1 July 2010

1 reference

Lancet Infectious Diseases

22 August 2017

published in

1 reference

22 August 2017

volume

10

1 reference

22 August 2017

issue

7

1 reference

22 August 2017

page(s)

464-469

1 reference

Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Time to act: global apathy towards HIV/AIDS is a crime against humanity.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

A review of barriers and facilitators of HIV treatment among injection drug users.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Disparity in health care: HIV, stigma, and marginalization in Nepal

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Predictors and Consequences of Negative Physician Attitudes Toward HIV-Infected Injection Drug Users

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Adherence in antiretroviral therapy: a review of qualitative studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Public Health Implications of Antiretroviral Therapy and HIV Drug Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Provider bias in the selection of non-nucleoside reverse transcriptase inhibitor and protease inhibitor-based highly active antiretroviral therapy and HIV treatment outcomes in observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Staging for antiretroviral therapy among HIV-infected drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Undue reliance on I(2) in assessing heterogeneity may mislead

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Chemokines and receptors in HIV encephalitis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Prevalence of HIV-1 resistant to antiretroviral drugs in 81 individuals newly infected by sexual contact or injecting drug use. Investigators of the Quebec Primary Infection Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Acute HIV infection: impact on the spread of HIV and transmission of drug resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

High prevalence of genotypic resistance to nucleoside reverse transcriptase inhibitors among therapy-naive individuals from the Warsaw cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Declining trend in transmission of drug-resistant HIV-1 in Amsterdam

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Differences in HIV disease progression by injecting drug use in HIV-infected persons in care

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

The prevalence of antiretroviral drug resistance in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Rates of antiretroviral resistance among HIV-infected patients with and without a history of injection drug use.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Prevalence of resistance-associated mutations in newly diagnosed HIV-1 patients in Greece.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Prevalence of transmitted HIV-1 drug resistance and the role of resistance algorithms: data from seroconverters in the CASCADE collaboration from 1987 to 2003.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Trends of antiretroviral drug resistance in treatment-naive patients with human immunodeficiency virus type 1 infection in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Adherence to HIV treatment among IDUs and the role of opioid substitution treatment (OST).

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Homelessness and psychological distress as contributors to antiretroviral nonadherence in HIV-positive injecting drug users

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Paradoxes of adherence and drug resistance to HIV antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

Reasons or excuses for avoiding meta-analysis in forest plots

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2810%2970097-9

7 January 2021

10.1016/S1473-3099(10)70097-9

Identifiers

DOI

1 reference

22 August 2017

1 reference